Keyphrases
Angiogenesis
100%
Thrombospondin-1 (TSP-1)
100%
Mimetic Peptide
100%
Preantral Follicles
100%
Follicular Atresia
100%
Follicle
75%
Atresia
75%
Follicular Angiogenesis
75%
Granulosa Cells
50%
Follicular Phase
50%
Novel Therapeutics
25%
Induced Apoptosis
25%
Inhibitory Effect
25%
Antiangiogenic Activity
25%
Twice Daily
25%
Ovulation
25%
Apoptotic Effect
25%
Polycystic Ovary Syndrome
25%
Marmoset
25%
Luteolysis
25%
Preantral
25%
Second Dose
25%
Plasma Progesterone
25%
Octapeptide
25%
Vascular Endothelial Growth Factor Inhibitors
25%
Ovulatory
25%
Dual Effect
25%
Dominant Follicle
25%
Abnormal Angiogenesis
25%
Ovulatory Cycle
25%
Depot Formulation
25%
Active Concentration
25%
In Vitro Angiogenesis Assay
25%
Marmoset Monkey
25%
Pharmacology, Toxicology and Pharmaceutical Science
Atresia
100%
Ovary Follicle Atresia
100%
Thrombospondin
100%
Callitrichinae
66%
Thrombospondin 1
66%
Antiangiogenic
33%
Haplorhini
33%
Ovary Polycystic Disease
33%
Vasculotropin Inhibitor
33%
Octapeptide
33%
Progesterone
33%
Agricultural and Biological Sciences
Follicle
100%
Follicular Atresia
100%
Angiogenesis
100%
Thrombospondin
100%
Granulosa Cell
28%
Thrombospondin 1
28%
Rat
14%
Ovulation
14%
Vascular Endothelial Growth Factor
14%
Menstrual Cycle
14%
Programmed Cell Death
14%
Blood Plasma
14%
Progesterone
14%
Biochemistry, Genetics and Molecular Biology
Peptide Mimetics
100%
Angiogenesis
100%
Thrombospondin
100%
Follicular Phase
28%
Callitrichinae
28%
Thrombospondin 1
28%
Haplorhini
14%
Ovulation
14%
Antiangiogenic Activity
14%
Menstrual Cycle
14%
Progesterone Blood Level
14%
Luteolysis
14%
Vascular Endothelial Growth Factor
14%
Programmed Cell Death
14%